These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33450542)

  • 1. 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies.
    Ghoteimi R; Braka A; Rodriguez C; Cros-Perrial E; Tai Nguyen V; Uttaro JP; Mathé C; Chaloin L; Ménétrier-Caux C; Jordheim LP; Peyrottes S
    Bioorg Chem; 2021 Feb; 107():104577. PubMed ID: 33450542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73 inhibition by purine cytotoxic nucleoside analogue-based diphosphonates.
    Dumontet C; Peyrottes S; Rabeson C; Cros-Perrial E; Géant PY; Chaloin L; Jordheim LP
    Eur J Med Chem; 2018 Sep; 157():1051-1055. PubMed ID: 30176535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
    Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
    J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Substituted 5'-Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73.
    Ghoteimi R; Nguyen VT; Rahimova R; Grosjean F; Cros-Perrial E; Uttaro JP; Mathé C; Chaloin L; Jordheim LP; Peyrottes S
    ChemMedChem; 2019 Aug; 14(15):1431-1443. PubMed ID: 31264794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-Methylguanosine monophosphate analogues with 5'-(1,2,3-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase.
    Kozarski M; Kubacka D; Wojtczak BA; Kasprzyk R; Baranowski MR; Kowalska J
    Bioorg Med Chem; 2018 Jan; 26(1):191-199. PubMed ID: 29195795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
    Junker A; Renn C; Dobelmann C; Namasivayam V; Jain S; Losenkova K; Irjala H; Duca S; Balasubramanian R; Chakraborty S; Börgel F; Zimmermann H; Yegutkin GG; Müller CE; Jacobson KA
    J Med Chem; 2019 Apr; 62(7):3677-3695. PubMed ID: 30895781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
    Beatty JW; Lindsey EA; Thomas-Tran R; Debien L; Mandal D; Jeffrey JL; Tran AT; Fournier J; Jacob SD; Yan X; Drew SL; Ginn E; Chen A; Pham AT; Zhao S; Jin L; Young SW; Walker NP; Leleti MR; Moschütz S; Sträter N; Powers JP; Lawson KV
    J Med Chem; 2020 Apr; 63(8):3935-3955. PubMed ID: 32212732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors.
    Sharif EU; Kalisiak J; Lawson KV; Miles DH; Newcomb E; Lindsey EA; Rosen BR; Debien LPP; Chen A; Zhao X; Young SW; Walker NP; Sträter N; Scaletti ER; Jin L; Xu G; Leleti MR; Powers JP
    J Med Chem; 2021 Jan; 64(1):845-860. PubMed ID: 33399453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39.
    Jeffrey JL; Lawson KV; Powers JP
    J Med Chem; 2020 Nov; 63(22):13444-13465. PubMed ID: 32786396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of WO2017098421: GSK's benzothiazine compounds as CD73 inhibitor filings.
    Gong YP; Wan RZ; Liu ZP
    Expert Opin Ther Pat; 2018 Feb; 28(2):167-171. PubMed ID: 29166791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73.
    Shi C; Chang L; Wang J; Dai J; Xu W; Tang J; Mei W; Zhang C; Wang Z; Liao Y; Zhang X; Jiang W; Zhang G; Zhao Z; Xu Y; Zhu L; Li H
    J Med Chem; 2024 Jun; 67(11):9686-9708. PubMed ID: 38809692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Expression Analysis of CD73 Inhibitors in Cervical Cancer.
    Iqbal J; Basharat A; Bano S; Abid SMA; Pelletier J; Sévigny J
    Med Chem; 2021; 17(8):866-874. PubMed ID: 32981507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor.
    Wang Y; Wang C; Zhu Y; Zhang Y; Chen B; Wu Y; Yao J; Miao Z
    Bioorg Med Chem Lett; 2021 Feb; 34():127758. PubMed ID: 33359608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylhydrazones: Design, synthesis and investigation of ectonucleotidase (ALP & e5'NT) inhibition activities.
    Younus HA; Hameed A; Mahmood A; Khan MS; Saeed M; Batool F; Asari A; Mohamad H; Pelletier J; Sévigny J; Iqbal J; Al-Rashida M
    Bioorg Chem; 2020 Jul; 100():103827. PubMed ID: 32402802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of β-hydroxyphosphonate nucleoside analogues as cytosolic 5'-nucleotidase II potential inhibitors: synthesis, in vitro evaluation and molecular modeling studies.
    Meurillon M; Marton Z; Hospital A; Jordheim LP; Béjaud J; Lionne C; Dumontet C; Périgaud C; Chaloin L; Peyrottes S
    Eur J Med Chem; 2014 Apr; 77():18-37. PubMed ID: 24607586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
    Scortichini M; Idris RM; Moschütz S; Keim A; Salmaso V; Dobelmann C; Oliva P; Losenkova K; Irjala H; Vaittinen S; Sandholm J; Yegutkin GG; Sträter N; Junker A; Müller CE; Jacobson KA
    J Med Chem; 2022 Feb; 65(3):2409-2433. PubMed ID: 35080883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.
    Du X; Moore J; Blank BR; Eksterowicz J; Sutimantanapi D; Yuen N; Metzger T; Chan B; Huang T; Chen X; Chen Y; Duong F; Kong W; Chang JH; Sun J; Zavorotinskaya T; Ye Q; Junttila MR; Ndubaku C; Friedman LS; Fantin VR; Sun D
    J Med Chem; 2020 Sep; 63(18):10433-10459. PubMed ID: 32865411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
    Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present).
    Nocentini A; Capasso C; Supuran CT
    Expert Opin Ther Pat; 2021 Oct; 31(10):867-876. PubMed ID: 33909515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach.
    Bhujbal SP; Hah JM
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.